{{Rsnum
|rsid=12145418
|Gene=ESRRG
|Chromosome=1
|position=216542978
|Orientation=plus
|GMAF=0.2796
|Gene_s=ESRRG
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 47.3 | 45.5 | 7.1
| HCB | 47.1 | 41.2 | 11.8
| JPT | 42.0 | 49.1 | 8.9
| YRI | 88.4 | 11.6 | 0.0
| ASW | 75.4 | 24.6 | 0.0
| CHB | 47.1 | 41.2 | 11.8
| CHD | 44.3 | 47.2 | 8.5
| GIH | 57.0 | 38.0 | 5.0
| LWK | 90.0 | 10.0 | 0.0
| MEX | 31.6 | 52.6 | 15.8
| MKK | 80.8 | 18.6 | 0.6
| TSI | 47.5 | 36.6 | 15.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=2E-6
  |OR=1.33
  |ORtxt=[1.104-1.604]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}